HANGZHOU, China, March 28, 2024 /PRNewswire/ Hangzhou Tigermed Consulting Co., Ltd. , a leading global provider of integrated research and development solutions for biopharmaceutical and.
Since 2022, the Initiative to Advance Decentralized Clinical Trials (the Initiative) has come together to identify issues and policy opportunities to advance decentralized clinical trials (DCTs).